Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Richard

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|May 24, 2006
Discovery of a novel shp2 protein tyrosine phosphatase inhibitorLiwei Chen, Shen-Shu Sung, M L Richard Yip, et al.
Molecular Oncology|May 25, 2015
CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonistSangjun Lee, Eileen L Heinrich, Lily Li, et al.
Marine Drugs|July 24, 2019
Cytotoxic Sesquiterpenoid Quinones and Quinols, and an 11-Membered Heterocycle, Kauamide, from the Hawaiian Marine Sponge <i>Dactylospongia elegans</i>Ram P Neupane, Stephen M Parrish, Jayanti Bhandari Neupane, et al.
Cancer Biology & Therapy|February 9, 2012
Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitorFan Yang, Veronica Jove, Shirley Chang, et al.
Cancer Research|September 28, 2013
A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistanceBingsen Zhou, Leila Su, Shuya Hu, et al.
Journal of Medicinal Chemistry|August 6, 2008
Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffoldsHarshani R Lawrence, Roberta Pireddu, Liwei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico dockingHarshani R Lawrence, Zhenyu Li, M L Richard Yip, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2007
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityKhandaker Siddiquee, Shumin Zhang, Wayne C Guida, et al.
Stem Cells and Development|May 3, 2018
Glucocorticoid Signaling Enhances Expression of Glucose-Sensing Molecules in Immature Pancreatic Beta-Like Cells Derived from Murine Embryonic Stem Cells In VitroNadiah Ghazalli, Xiaoxing Wu, Stephanie Walker, et al.
Molecular Cancer Therapeutics|October 6, 2011
Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppressionJinbo Gao, Yujun Wang, Quanhua Xing, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|May 24, 2006
Discovery of a novel shp2 protein tyrosine phosphatase inhibitorLiwei Chen, Shen-Shu Sung, M L Richard Yip, et al.
Molecular Oncology|May 25, 2015
CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonistSangjun Lee, Eileen L Heinrich, Lily Li, et al.
Marine Drugs|July 24, 2019
Cytotoxic Sesquiterpenoid Quinones and Quinols, and an 11-Membered Heterocycle, Kauamide, from the Hawaiian Marine Sponge <i>Dactylospongia elegans</i>Ram P Neupane, Stephen M Parrish, Jayanti Bhandari Neupane, et al.
Cancer Biology & Therapy|February 9, 2012
Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitorFan Yang, Veronica Jove, Shirley Chang, et al.
Cancer Research|September 28, 2013
A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistanceBingsen Zhou, Leila Su, Shuya Hu, et al.
Journal of Medicinal Chemistry|August 6, 2008
Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffoldsHarshani R Lawrence, Roberta Pireddu, Liwei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2009
Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico dockingHarshani R Lawrence, Zhenyu Li, M L Richard Yip, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2007
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityKhandaker Siddiquee, Shumin Zhang, Wayne C Guida, et al.
Stem Cells and Development|May 3, 2018
Glucocorticoid Signaling Enhances Expression of Glucose-Sensing Molecules in Immature Pancreatic Beta-Like Cells Derived from Murine Embryonic Stem Cells In VitroNadiah Ghazalli, Xiaoxing Wu, Stephanie Walker, et al.
Molecular Cancer Therapeutics|October 6, 2011
Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppressionJinbo Gao, Yujun Wang, Quanhua Xing, et al.
Pageof 3